Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection

Journal of Medical Virology

Volumn 86, Issue 8, 2014, Pages 1393-1401

  Reddy, Vijayalakshmi ^a   Mani, Reeta Subramaniam ^a   Desai, Anita ^a   Ravi, Vasanthapuram ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Biomarkers of Chikungunya severity; Cytokines chemokines in Chikungunya

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MIG CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS RNA; BIOLOGICAL MARKER; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CLINICAL ARTICLE; CONJUNCTIVA DISEASE; CONTROLLED STUDY; CYTOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFLAMMATION; MALE; MYALGIA; NONHUMAN; PROTEIN BLOOD LEVEL; RASH; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; AGED; BLOOD; CHEMISTRY; IMMUNOASSAY; IMMUNOLOGY; INDIA; ISOLATION AND PURIFICATION; MIDDLE AGED; PLASMA; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; CYTOKINES; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN M; INDIA; MALE; MIDDLE AGED; PLASMA; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL LOAD; YOUNG ADULT;

EID: 84901831587     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23875     Document Type: Article

References (31)

1. Beltrame A, Angheben A, Bisoffi Z, Monteiro G, Marocco S, Calleri G, Lipani F, Gobbi F, Canta F, Castelli F, Gulletta M, Bigoni S, Del Punta V, Iacovazzi T, Romi R, Nicoletti L, Ciufolini MG, Rorato G, Negri C, Viale P. 2007. Imported Chikungunya Infection, Italy. Emerg Infect Dis 13:1264-1266.
2. Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Becquart JP, Wengling C, Michault A, Paganin F. 2007. Outbreak of chikungunya on Reunion Island: Early clinical and laboratory features in 157 adult patients. Clin Infect Dis 44:1401-1407.
3. Bouquillard E, Combe B. 2009. Rheumatoid arthritis after Chikungunya fever: A prospective follow-up study of 21 cases. Ann Rheum Dis 68:1505-1506.
4. Brighton SW. 1984. Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study. S Afr Med J 66:217-218.
5. Brighton SW, Prozesky OW, de la Harpe AL. 1983. Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J 63:313-315.
6. Chaaitanya IK, Muruganandam N, Sundaram SG, Kawalekar O, Sugunan AP, Manimunda SP, Ghosal SR, Muthumani K, Vijayachari P. 2011. Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. Viral Immunol 24:265-271.
7. Chen CI, Clark DC, Pesavento P, Lerche NW, Luciw PA, Reisen WK, Brault AC. 2010. Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model. Am J Trop Med Hyg 83:1249-1258.
8. Chopra A, Anuradha V, Ghorpade R, Saluja M. 2012. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: A 2-year prospective rural community study. Epidemiol Infect 140:842-850.
9. Chow A, Her Z, Ong EK, Chen JM, Dimatatac F, Kwek DJ, Barkham T, Yang H, Rénia L, Leo YS, Ng LF. 2011. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149-157.
10. Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P. 2012. Chikungunya disease: Infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 6:e1446.
11. Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O, Quenel P, Germonneau P, Quatresous I. 2009. Atypical Chikungunya virus infections: Clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect 137:534-541.
12. Ganu MA, Ganu AS. 2011. Post-chikungunya chronic arthritis-our experience with DMARDs over two year follow up. J Assoc Physicians India 59:83-86.
13. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, Tallet F, Moiton MP, Gauzère BA, Bruniquet S, Jaffar Bandjee Z, Morbidelli P, Martigny G, Jolivet M, Gay F, Grandadam M, Tolou H, Vieillard V, Debré P, Autran B, Gasque P. 2010. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 184:5914-5927.
14. Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, Gaibani P, Cavrini F, Pierro A, Rossini G, Cameron MJ, Bermejo-Martin JF, Paquette SG, Xu L, Danesh A, Farooqui A, Borghetto I, Kelvin DJ, Sambri V, Rubino S. 2011. Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 5:e1279.
15. Kokkonen H, Söderström I, Rocklöv J, Hallmans G, Lejon K, Rantapää Dahlqvist S. 2010. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 62:383-391.
16. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, de Lamballerie X, Suhrbier A, Cherel Y, Le Grand R, Roques P. 2010. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 120:894-906.
17. Lanciotti RS, Kosoy OL, Laven JJ, Panella AJ, Velez JO, Lambert AJ, Campbell GL. 2007. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 13:764-767.
18. Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, Tarkowski A, van Rooijen N, Fraser RJ, Mahalingam S. 2008. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis 197:1585-1593.
19. Lohachanakul J, Phuklia W, Thannagith M, Thonsakulprasert T, Ubol S. 2012. High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand. Microbiol Immunol 56:134-138.
20. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, Sudeep AB, Muruganandam N, Chaitanya IK, Guruprasad DR. 2010. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104:392-399.
21. Messaoudi I, Vomaske J, Totonchy T, Kreklywich CN, Haberthur K, Springgay L, Brien JD, Diamond MS, Defilippis VR, Streblow DN. 2013. Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity. PLoS Negl Trop Dis 7:e2343.
22. Ng LF, Chow A, Sun YJ, Kwek DJ, Lim PL, Dimatatac F, Ng LC, Ooi EE, Choo KH, Her Z, Kourilsky P, Leo YS. 2009. IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS ONE 4:e4261.
23. Oliver M, Grandadam M, Marimoutou C, Rogier C, Botelho-Nevers E, Tolou H, Moalic JL, Kraemer P, Morillon M, Morand JJ, Jeandel P, Parola P, Simon F. 2009. Persisting mixed cryoglobulinemia in Chikungunya infection. PLoS Negl Trop Dis 3:e374.
24. Pialoux G, Gaüzère BA, Jauréguiberry S, Strobel M. 2007. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7:319-327.
25. Rantapää-Dahlqvist S, Boman K, Tarkowski A, Hallmans G. 2007. Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis 6:121-123.
26. Ravi V. 2006. Re-emergence of Chikungunya virus in India. Indian J Med Microbiol 24:83-84.
27. Reddy V, Ravi V, Desai A, Parida M, Powers AM, Johnson BW. 2012. Utility of IgM ELISA, TaqMan real-time PCR, reverse transcription PCR, and RT-LAMP assay for the diagnosis of Chikungunya fever. J Med Virol 84:1771-1778.
28. Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S. 2011. Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis 204:1026-1030.
29. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM. 2011. The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis 204:115-123.
30. Waymouth HE, Zoutman DE, Towheed TE. 2013. Chikungunya-related arthritis: Case report and review of the literature. Semin Arthritis Rheum 43:273-278.
31. Zou KH, Tuncali K, Silverman SG. 2003. Correlation and simple linear regression. Radiol 227:617-628.